Kevin M. Slawin
Kevin M. Slawin
Director, Vanguard Urologic Institute at Memorial Hermann Medical Group
Verified email at vanguardurology.com - Homepage
Title
Cited by
Cited by
Year
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ...
New England Journal of Medicine 349 (25), 2387-2398, 2003
22972003
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
14811998
Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial
JB Jemmott III, LS Jemmott, GT Fong
Jama 279 (19), 1529-1536, 1998
9471998
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ...
Journal of clinical oncology: official journal of the American Society of …, 2007
8852007
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ...
Jama 291 (11), 1325-1332, 2004
6922004
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens
P Swindle, JA Eastham, M Ohori, MW Kattan, T Wheeler, N Maru, ...
The Journal of urology 174 (3), 903-907, 2005
5562005
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
4292011
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
WJ Catalona, PC Southwick, KM Slawin, AW Partin, MK Brawer, ...
Urology 56 (2), 255-260, 2000
4052000
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors
MW Kattan, JA Eastham, TM Wheeler, N Maru, PT Scardino, ...
The Journal of urology 170 (5), 1792-1797, 2003
3952003
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer
JL Gore, SF Shariat, BJ Miles, D Kadmon, N Jiang, TM Wheeler, ...
The Journal of urology 165 (5), 1554-1559, 2001
3032001
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer
M Ohori, MW Kattan, H Koh, N Maru, KM Slawin, S Shariat, M Muramoto, ...
The Journal of urology 171 (5), 1844-1849, 2004
2962004
Survivin expression is associated with features of biologically aggressive prostate carcinoma
SF Shariat, Y Lotan, H Saboorian, SM Khoddami, CG Roehrborn, ...
Cancer 100 (4), 751-757, 2004
2852004
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
SF Shariat, B Andrews, MW Kattan, JH Kim, TM Wheeler, KM Slawin
Urology 58 (6), 1008-1015, 2001
2672001
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
SF Shariat, CG Roehrborn, JD McConnell, S Park, N Alam, TM Wheeler, ...
Journal of Clinical Oncology 25 (4), 349-355, 2007
2532007
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo
ED Crawford, SS Wilson, JD McConnell, KM Slawin, MC Lieber, JA Smith, ...
The Journal of urology 175 (4), 1422-1427, 2006
2462006
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue
SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, LS Marks, W Song, ...
Cancer research 60 (3), 756-759, 2000
2422000
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with …
MW Kattan, SF Shariat, B Andrews, K Zhu, E Canto, K Matsumoto, ...
Journal of Clinical Oncology 21 (19), 3573-3579, 2003
2362003
“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, RL Wolfert, ...
Urology 55 (1), 41-45, 2000
2332000
Preoperative plasma levels of transforming growth factor beta1 (TGF-β1) strongly predict progression in patients undergoing radical prostatectomy
SF Shariat, M Shalev, A Menesses-Diaz, IY Kim, MW Kattan, TM Wheeler, ...
Journal of Clinical Oncology 19 (11), 2856-2864, 2001
2222001
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy
AK Leventis, SF Shariat, MW Kattan, EB Butler, TM Wheeler, KM Slawin
Journal of clinical oncology 19 (4), 1030-1039, 2001
2132001
The system can't perform the operation now. Try again later.
Articles 1–20